XRAY
17
-12
MNST
68
3
PRU
59
5
PCG
93
2
PM
54
-2
AON
60
-2
GT
64
-3
EXC
37
2
VRSK
82
-2
LNC
50
5
UPS
41
-4
M
31
-5
FDX
44
-7
SJM
17
-4
AN
54
2
TGT
49
5
JNJ
39
-2
SLB
57
4
MLM
63
-4
PX
79
6
XRAY
17
-12
MNST
68
3
PRU
59
5
PCG
93
2
PM
54
-2
AON
60
-2
GT
64
-3
EXC
37
2
VRSK
82
-2
LNC
50
5
UPS
41
-4
M
31
-5
FDX
44
-7
SJM
17
-4
AN
54
2
TGT
49
5
JNJ
39
-2
SLB
57
4
MLM
63
-4
PX
79
6
Financhill
Back

OrganiGram Holdings 10K Form

Sell
27

OGI
OrganiGram Holdings

Last Price:
1.59
Seasonality Move:
6.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OGI News And Ratings

See the #1 stock for the next 7 days that we like better than OGI

OGI Financial Statistics

Sales & Book Value

Annual Sales: $119.77M
Cash Flow: $-3.46M
Price / Cash Flow: 0
Annual Sales: $2.08
Price / Book: 0.74

Profitability

EPS (TTM): -0.84200
Net Income (TTM): $-186.7M
Gross Margin: $28.15M
Return on Equity: -77.24%
Return on Assets: -67.04%

OrganiGram Holdings Earnings Forecast

Key OrganiGram Holdings Financial Ratios

  • The Gross Profit Margin over the past 9 years for OGI is 23.51%.
  • The Selling, General & Administrative Expenses for OGI have been equal to 44.55% of Gross Profit Margin.
  • The Research & Development expenses have been 8.17% of Revenue.
  • The Interest Expense is -0.12% of Operating Income.
  • The Net Earning history of OGI is -153.80% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

OrganiGram Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OGI
Website: organigram.ca

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.29
Quick Ratio: 2.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OGI Technical Analysis vs Fundamental Analysis

Sell
27
OrganiGram Holdings (OGI) is a Sell

Is OrganiGram Holdings a Buy or a Sell?